Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Loupy

Showing results (101-110 of 206) with videos related to

Pageof 21
Sort By:
Transplantation|July 21, 2018
A 2018 Reference Guide to the Banff Classification of Renal Allograft PathologyCandice Roufosse, Naomi Simmonds, Marian Clahsen-van Groningen, et al.
Journal of the American Society of Nephrology : JASN|January 4, 2015
Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney AllograftsAlexandre Loupy, Dewi Vernerey, Claire Tinel, et al.
Transplantation|October 24, 2014
De Novo Donor-Specific Human Leukocyte Antigen Antibodies in Nonsensitized Kidney Transplant Recipients After T Cell-Mediated RejectionJonathan-Maurice Chemouny, Caroline Suberbielle, Marion Rabant, et al.
Journal of the American Society of Nephrology : JASN|April 5, 2014
Molecular microscope strategy to improve risk stratification in early antibody-mediated kidney allograft rejectionAlexandre Loupy, Carmen Lefaucheur, Dewi Vernerey, et al.
Frontiers in Immunology|January 7, 2025
Tacrolimus to belatacept conversion in proteinuric kidney transplant recipientsOrhan Efe, Ayman Al Jurdi, Morgan Mabey Eiting, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 7, 2022
Proposed Definitions of Antibody-Mediated Rejection for Use as a Clinical Trial Endpoint in Kidney TransplantationCandice Roufosse, Jan Ulrich Becker, Marion Rabant, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 7, 2022
Proposed Definitions of T Cell-Mediated Rejection and Tubulointerstitial Inflammation as Clinical Trial Endpoints in Kidney TransplantationDaniel Seron, Marion Rabant, Jan Ulrich Becker, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 24, 2023
Validation of the clinical utility of microRNA as noninvasive biomarkers of cardiac allograft rejection: A prospective longitudinal multicenter studyGuillaume Coutance, Maud Racapé, Guillaume Baudry, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 2025
Evaluation of a Decentralized Donor-Derived Cell-Free DNA Assay for Kidney Allograft Rejection MonitoringAlexandre Loupy, Anaïs Certain, Narin S Tangprasertchai, et al.
Circulation. Heart Failure|October 6, 2022
Clinical Prediction Model for Antibody-Mediated Rejection: A Strategy to Minimize Surveillance Endomyocardial Biopsies After Heart TransplantationGuillaume Coutance, Evan Kransdorf, Olivier Aubert, et al.
Pageof 21

Showing results (101-110 of 206) with videos related to

Sort By:
Pageof 21
Transplantation|July 21, 2018
A 2018 Reference Guide to the Banff Classification of Renal Allograft PathologyCandice Roufosse, Naomi Simmonds, Marian Clahsen-van Groningen, et al.
Journal of the American Society of Nephrology : JASN|January 4, 2015
Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney AllograftsAlexandre Loupy, Dewi Vernerey, Claire Tinel, et al.
Transplantation|October 24, 2014
De Novo Donor-Specific Human Leukocyte Antigen Antibodies in Nonsensitized Kidney Transplant Recipients After T Cell-Mediated RejectionJonathan-Maurice Chemouny, Caroline Suberbielle, Marion Rabant, et al.
Journal of the American Society of Nephrology : JASN|April 5, 2014
Molecular microscope strategy to improve risk stratification in early antibody-mediated kidney allograft rejectionAlexandre Loupy, Carmen Lefaucheur, Dewi Vernerey, et al.
Frontiers in Immunology|January 7, 2025
Tacrolimus to belatacept conversion in proteinuric kidney transplant recipientsOrhan Efe, Ayman Al Jurdi, Morgan Mabey Eiting, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 7, 2022
Proposed Definitions of Antibody-Mediated Rejection for Use as a Clinical Trial Endpoint in Kidney TransplantationCandice Roufosse, Jan Ulrich Becker, Marion Rabant, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 7, 2022
Proposed Definitions of T Cell-Mediated Rejection and Tubulointerstitial Inflammation as Clinical Trial Endpoints in Kidney TransplantationDaniel Seron, Marion Rabant, Jan Ulrich Becker, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 24, 2023
Validation of the clinical utility of microRNA as noninvasive biomarkers of cardiac allograft rejection: A prospective longitudinal multicenter studyGuillaume Coutance, Maud Racapé, Guillaume Baudry, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 2025
Evaluation of a Decentralized Donor-Derived Cell-Free DNA Assay for Kidney Allograft Rejection MonitoringAlexandre Loupy, Anaïs Certain, Narin S Tangprasertchai, et al.
Circulation. Heart Failure|October 6, 2022
Clinical Prediction Model for Antibody-Mediated Rejection: A Strategy to Minimize Surveillance Endomyocardial Biopsies After Heart TransplantationGuillaume Coutance, Evan Kransdorf, Olivier Aubert, et al.
Pageof 21